Black patients with advanced heart failure received potentially life-saving therapies half as often as white patients, a study published in the AHA journal Circulation: Heart Failure found.
The study, supported by the National Institutes of Health, followed 377 patients receiving treatment at 21 centers in the U.S. The analysis found 22 percent of white adults received a heart transplant or ventricular assist device compared with only 11 percent of Black adults.
The findings underscore a possible racial bias in end-stage heart failure, according to an NIH release.